Highlight Therapeutics raises €22.6M with Advent Life Sciences, Columbus Venture Partners in Spain
04 September 2025
04 September 2025
Total investments received (USD): 43.8M
Round value (USD): 26.33M
Company: Highlight Therapeutics
Related deals
Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
Investments
03 September 2025
AMSilk raised €22m in debt and €30m in post series C equity funding led by Athos, joined by insiders MIG Capital and Novo Holdings.
Investments
01 September 2025
Ketryx closed a $39 million Series B round led by Transformation Capital, joined by Lightspeed Venture, MIT’s E14 Fund, Ubiquity Ventures, and 53 Stations.
Investments
29 August 2025
Omnio in a €30 million debt to equity conversion alongside a new equity issuance with Achilles Capital
Investments
17 August 2025
Maisa raised $25m in seed funding led by Creandum, joined by Forgepoint Capital, NFX, and Village Global.
Investments
13 August 2025
Belgium
Netherlands
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal